Muñoz, C.; Tai, X.; Arias, J.; Eisen, A.; Chaudhry, M.; Gavura, S.; Chan, K.K.W.
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Curr. Oncol. 2024, 31, 1633-1644.
https://doi.org/10.3390/curroncol31030124
AMA Style
Muñoz C, Tai X, Arias J, Eisen A, Chaudhry M, Gavura S, Chan KKW.
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current Oncology. 2024; 31(3):1633-1644.
https://doi.org/10.3390/curroncol31030124
Chicago/Turabian Style
Muñoz, Caroline, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, and Kelvin K. W. Chan.
2024. "Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer" Current Oncology 31, no. 3: 1633-1644.
https://doi.org/10.3390/curroncol31030124
APA Style
Muñoz, C., Tai, X., Arias, J., Eisen, A., Chaudhry, M., Gavura, S., & Chan, K. K. W.
(2024). Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer. Current Oncology, 31(3), 1633-1644.
https://doi.org/10.3390/curroncol31030124